Madrigal Pharmaceuticals, Inc. (MDGL)

Madrigal Pharmaceuticals, Inc. records an AlphaScore of 39/100 in the Healthcare sector, accompanied by a caution signal and a market capitalization of $10.90 billion. Key fundamentals feature a high gross margin of 91.48% and a massive revenue growth of 432.05%. A key strength is its surging sales growth, whereas a prominent risk is represented by its negative net margin of -30.08%. Evidence is limited to the provided snapshot date of 2026-10-11.

Written 11/10/2026, 00:43:07 UTC · Snapshot 11/10/2026